The Canary Acuity™ Comprehensive Gene Profiling (CGP) test is CLIA-certified and CAP-Accredited for solid and liquid tumors. This test examines 1091 genes, including dozens that are not found in other competing tests, offering a thorough analysis for personalized cancer care. This comprehensive approach enables tailored treatment strategies such as targeted therapy or immunotherapy.
Canary Focus™ is a smaller gene panel test which is CLIA-certified and CAP-Accredited for solid and liquid tumors. This more focused and streamlined gene panel can be equally effective in identifying relevant mutations for targeted therapies or other actionable clinical interventions. Our test, tailored for cancer patients seeking personalized treatment recommendations or longitudinal monitoring, accurately detects genetic mutations crucial for targeted therapy selection.
DNA which tumors shed into blood is called circulating tumor DNA (ctDNA). As a consequence, peripheral blood can be used as a source of tumor DNA to monitor disease status. Sometimes an analysis of ctDNA provides an oncologist with critical information earlier than is possible with other types of diagnostic tests, e.g., MRI or CT scan. ctDNA findings can help to detect the recurrence of tumor or progression of disease earlier than with other diagnostic tests. Hence, ctDNA results can allow oncologists to monitor a patient’s disease and make treatment decisions sooner than would otherwise be possible. The Canary Pulse™ Liquid Biopsy analyzes an extensive panel of 468 carefully selected cancer-related genes.
From early detection to personalized treatment strategies, our pipeline team is constantly working to expand our diagnostic capabilities, ensuring patients have access to the most advanced tools at every stage of their cancer journey.
At Canary Oncoceutics, we are driven by the belief that science can empower patients to conquer cancer. We rigorously apply our scientific expertise to create innovative diagnostic tools, delivering reliable results that enable informed and confident decision-making.
Canary Oncoceutics is at the forefront of cancer diagnostics, developing tests that provide both early detection and personalized treatment guidance. Our innovative tests can identify cancer before you experience symptoms, or provide invaluable information about the genes driving your specific cancer, empowering you and your doctor to choose the most effective, personalized treatment plan. Through rigorous clinical trials, we are committed to ensuring the safety and reliability of our tests, delivering innovative solutions that improve patient outcomes.
Canary Oncoceutics is committed to fostering collaborative research initiatives. We carefully evaluate research proposals based on their scientific rigor, practical feasibility, and alignment with our key areas of research. We provide comprehensive support to selected projects, which may include funding, logistical assistance, and access to our specialized resources.
Explore opportunities to partner with Canary Oncoceutics and integrate our cutting-edge diagnostic tests into your practice. Together, we can improve patient outcomes through early detection and personalized treatment strategies.
Get immediate answers to frequently asked questions about our tests, services, and research. Our FAQ section provides essential information for providers seeking to learn more about Canary Oncoceutics.
Discover how Canary Oncoceutics is contributing to cancer research and learn about opportunities to collaborate with us on academic research projects. Explore the clinical studies and advances that are driving progress in cancer diagnostics.
Have a specific medical question about our tests or services? Contact our dedicated medical team for expert insights and personalized guidance to support your clinical decision-making.
Discover how Canary Oncoceutics can empower you to take control of your health with innovative diagnostic tests, providing valuable insights into early detection and personalized treatment strategies
Learn about the simple steps involved in our testing process, from sample collection to results, and how our personalized approach can inform your cancer care decisions.
Explore educational resources that explain the connection between genes and cancer, empowering you with the knowledge to understand your genetic risk and make informed choices.
Connect with inspiring stories from patients who have benefited from Canary Oncoceutics' tests, gaining valuable insights and encouragement throughout your cancer journey.
Take the next step by scheduling a consultation with our experienced genetic counselors, who can provide personalized guidance and answer your questions about genetic testing and cancer prevention.
Have questions or need assistance? Our friendly and knowledgeable support team is ready to help. Contact us to learn more about our tests, services, and how we can support your health journey.
Stay informed about the latest developments at Canary Oncoceutics, including new test launches, research breakthroughs, partnerships, and company announcements.
Dive into our blog for insightful articles, expert commentary, and valuable information on cancer prevention, early detection, genetics, and personalized treatment strategies.
Explore upcoming conferences, webinars, and other events where Canary Oncoceutics will be present, showcasing our latest research and connecting with the medical community
Access our official press releases for the latest company news, including announcements of new partnerships, clinical trial results, and other significant developments.
Learn about Canary Oncoceutics' mission, vision, and core values, and how we are dedicated to advancing cancer diagnostics and improving patient outcomes through innovation and collaboration.
Get to know the talented individuals behind Canary Oncoceutics, including our scientists, researchers, medical professionals, and business leaders who are dedicated to making a difference in the fight against cancer.
Discover the expertise and insights of our distinguished advisory board, comprised of leading experts in oncology, genetics, and healthcare, who provide invaluable guidance to Canary Oncoceutics.
Read a message from our CEO, sharing their vision for the future of Canary Oncoceutics, our commitment to patients, and our dedication to innovation and progress in cancer diagnostics.
Connect with us! Find our contact information, including phone numbers, email addresses, and a contact form, so you can easily reach out to our team with any questions or inquiries.
Authentic testimonials from customers who have experienced the value of our products and services. Their words speak to our dedication to quality and customer satisfaction.
Stay informed, stay productive with all the latest from Canary Onco.
Enter your email bellow to get started with Canary Onco.